CompletedNCT04236375

The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction

Sponsor: Sun Yat-sen University

Trial Details

Condition	Eye Movement Disorder, Cognitive Dysfunction
Status	Completed
Participants	1,539
Est. Completion	30 July 2025
Last Updated	13 Apr 2026

Primary Outcome

Area under the curve

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * ①Subjects who are diagnosed as mild cognitive decline, Alzheimer's disease, Vascular dementia, Lewy body dementia, Frontotemporal dementia, other dementia and normal by neurologist. * ②Subjects who can cooperate with the inspection. * ③Subjects who agree to participate in the study and sign the consent form Exclusion Criteria: * ①Subjects who cannot do the inspection. * ②Subjects who suffer from diseases that compromise the inspection.

Trial Sites

Countries

China

View Registry Entry

Related Analysis

Completed Study Validates AI Eye-Tracking Platform for Cognitive Dysfunction Screening — Implications for Early Detection

A completed study of 1,539 participants validates an AI platform using eye movement analysis to screen for cognitive dysfunction across the dementia spectrum. Results could transform early detection approaches in clinical practice.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service